Biolifesolutions
NASDAQ: BLFSBothell, US · Delaware corporation · 1 known investors
BioLife Solutions provides biopreservation media, cell culture optimization products, storage systems, and closed-system manufacturing solutions for cell and gene therapy development and production. The company serves bioprocess engineers, therapy developers, and contract development and manufacturing organizations (CDMOs) navigating clinical trials and commercial-scale manufacturing.
Founders & leadership
RE
Rachel EllingsonDirector
JG
Joydeep GoswamiDirector
AD
Amy DuRossDirector
KF
Karen FosterExecutive Officer
TW
Troy WichtermanExecutive Officer
MR
Michael RiceExecutive Officer, Director
SA
Sarah AebersoldExecutive Officer
JS
Joseph SchickDirector
AM
Aby MathewExecutive Officer
TB
Todd BerardExecutive Officer
RD
Roderick De GreefExecutive Officer, Director
GP
Geraint PhillipsExecutive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$10.4MraisedOct 2023 · 1 investors · BiotechnologyRule 506(b)
▶$10.4MraisedOct 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rachel EllingsonDirector
- Joydeep GoswamiDirector
- Amy DuRossDirector
- Karen FosterExecutive Officer
- Troy WichtermanExecutive Officer
- Michael RiceExecutive Officer, Director
- Sarah AebersoldExecutive Officer
- Joseph SchickDirector
- Aby MathewExecutive Officer
- Todd BerardExecutive Officer
- Roderick De GreefExecutive Officer, Director
- Geraint PhillipsExecutive Officer
- Tim MooreDirector
- Offering amount
- $10.4M
- Amount sold
- $10.4M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.